Comparison of the safety and efficacy of PABO above or below the ovarian artery during cesarean delivery in patients with coexisting placenta accreta and placenta previa
- PMID: 33889683
- PMCID: PMC8049993
- DOI: 10.1016/j.ejro.2021.100344
Comparison of the safety and efficacy of PABO above or below the ovarian artery during cesarean delivery in patients with coexisting placenta accreta and placenta previa
Abstract
Purpose: To determine the effect of ovarian arteries on the use of prophylactic abdominal aortic balloon occlusion (PABO) in patients with coexisting placenta accreta and placenta previa.
Methods: Thirty-two pregnant women with coexisting placenta accreta and placenta previa treated with PABO in our hospital during 2013-2020 were retrospectively analyzed. The patients were divided into two groups: one with infra-renal abdominal aortic balloon occlusion above the ovarian artery (Group A, n = 15) and the other with occlusion below the ovarian artery (Group B, n = 17). Medical records and relevant imaging of all patients were reviewed. All Cesarean deliveries were scheduled and we decided to perform hysterectomy based on the surgical findings.
Results: Patients in both groups were similar in terms of age, gravidity history, and status of placenta. Regarding their outcomes, estimated blood loss was not significantly different in both groups, although it was lower in Group B than in Group A (3949.5 vs. 4333.8 ml). The other tested parameters did not show any difference. The uterus was preserved in 13 (41%) patients. No access-related or balloon occlusion-related complications occurred in either group.
Conclusions: PABO was safe. However, the balloon location (above or below the ovarian arteries) did not influence the outcomes. Further evaluation and prospective studies are required to evaluate the safety and efficacy of balloon occlusion above or below the ovarian artery in patients with coexisting placenta accreta and placenta previa.
Keywords: CTCAE, common terminology criteria for adverse events; EBL, estimated blood loss; MAP, morbidly adherent placenta; Ovarian artery; PABO, prophylactic abdominal aortic balloon occlusion; Placenta accreta; Placenta previa; Prophylactic abdominal aortic balloon occlusion (PABO); US, ultrasound.
© 2021 The Authors.
Conflict of interest statement
The authors report no declarations of interest.
Figures


Similar articles
-
Safety and Efficacy of Aortic Vs Internal Iliac Balloon Occlusion for Cesarean Delivery in Coexisting Placenta Accreta and Placenta Previa.Cardiovasc Intervent Radiol. 2020 Sep;43(9):1277-1284. doi: 10.1007/s00270-020-02548-9. Epub 2020 Jun 12. Cardiovasc Intervent Radiol. 2020. PMID: 32533311
-
MRI-Based Risk Factors for Adverse Maternal Outcomes in Prophylactic Aortic Balloon Occlusion for Placenta Accreta Spectrum and Placenta Previa.Diagnostics (Basel). 2024 Feb 4;14(3):333. doi: 10.3390/diagnostics14030333. Diagnostics (Basel). 2024. PMID: 38337849 Free PMC article.
-
Outcomes of prophylactic abdominal aortic balloon occlusion in patients with placenta previa accreta: a propensity score matching analysis.BMC Pregnancy Childbirth. 2022 Jun 20;22(1):502. doi: 10.1186/s12884-022-04837-2. BMC Pregnancy Childbirth. 2022. PMID: 35725388 Free PMC article.
-
The effect prophylactic internal iliac artery balloon occlusion in patients with placenta previa or placental accreta spectrum: a systematic review and meta-analysis.Reprod Biol Endocrinol. 2021 Mar 4;19(1):40. doi: 10.1186/s12958-021-00722-3. Reprod Biol Endocrinol. 2021. PMID: 33663536 Free PMC article.
-
Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2019 Jan 15;19(1):30. doi: 10.1186/s12884-019-2175-0. BMC Pregnancy Childbirth. 2019. PMID: 30646863 Free PMC article.
Cited by
-
Aortic balloon occlusion for placenta accreta spectrum: the higher, the better?Arch Gynecol Obstet. 2023 May;307(5):1657-1658. doi: 10.1007/s00404-022-06681-3. Epub 2022 Jul 11. Arch Gynecol Obstet. 2023. PMID: 35816206 No abstract available.
References
-
- Fan Y., Gong X., Wang N., Mu K., Feng L., Qiao F., Chen S., Zeng W., Liu H., Wu Y., Zhou Q., Tian Y., Li Q., Yang M., Li F., He M., Beejadhursing R., Deng D. A prospective observational study evaluating the efficacy of prophylactic internal iliac artery balloon catheterization in the management of placenta previa-accreta: a STROBE compliant article. Medicine. 2017;96(45):e8276. - PMC - PubMed
-
- Shih J.C., Liu K.L., Shyu M.K. Temporary balloon occlusion of the common iliac artery: new approach to bleeding control during cesarean hysterectomy for placenta percreta. Am. J. Obstet. Gynecol. 2005;193(5):1756–1758. - PubMed
-
- Peng W., Shen L., Wang S., Wang H. Retrospective analysis of 586 cases of placenta previa and accreta. J. Obstet. Gynaecol. 2020;40(5):609–613. - PubMed
-
- Wei Y., Luo J., Luo D. Comparison of efficacy between internal iliac artery and abdominal aorta balloon occlusions in pernicious placenta previa patients with placenta accrete. Gynecol. Obstet. Invest. 2019;84(4):343–349. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources